By: Dr. Srivathsan V. Raghavan, DrPH
Keywords: Public health leadership, occupational health policy, workplace health intervention, health disparities in chronic illness, systems-level healthcare administration, health equity models.
A Prologue
You know the feeling: a throbbing, one-sided headache that shows up out of nowhere, drags nausea and light sensitivity along with it, and makes even a normal work email feel impossible to write. That’s a migraine, not “just a bad headache.” It’s a full-blown neurological disease, and it happens to be the second leading cause of disability-years worldwide, hitting people hardest during their prime working years (Leonardi & Raggi, 2019).
For most of us, migraine is something we hear about, shrug off, or quietly power through at our desks. But from a public health standpoint, that “powering through” is exactly the problem. This piece breaks down what’s actually happening in the brain during a migraine, who gets hit hardest at work, why the real financial damage isn’t what you’d expect, and what public health leaders can actually do about it.
An Assessment for Enlightenment
Let’s start with the brain. A migraine isn’t random pain; it’s a coordinated (if unwelcome) chain reaction. It often starts in the hypothalamus, the part of your brain that reacts to stress, disrupted sleep, and even shifts in barometric pressure (Charles & Brennan, 2009). From there, the brainstem becomes involved, and regions involved in sensory processing and pain regulation become hyperexcitable (Goadsby, 2012). That’s followed by a wave of intense nerve activity that spreads across the brain, sometimes called “cortical spreading depolarization,” which is essentially why some people see flashing lights or blind spots (an aura) before the pain even hits (Frimpong-Manson et al., 2024; Purves et al., 2001). By the time the headache itself arrives, your nervous system is so keyed up that ordinary light, sound, or even a light touch can feel unbearable.
Migraines aren’t one-size-fits-all, either. About three-quarters of cases happen without an aura, while the rest come with those visual or sensory warning signs (American Migraine Foundation, 2021). Frequency matters too: “episodic” migraine means fewer than 15 headache days per month, while “chronic” migraine means 15 or more headache days per month for at least 3 consecutive months (National Institute of Neurological Disorders and Stroke, 2026).
Here’s where it gets interesting for the workplace. Migraine doesn’t strike randomly across job types. People in high-demand, low-control roles, like sales, clerical, and administrative work, report significantly higher rates of severe migraine and chronic headache than workers in other fields (Kessler et al., 2010). Shift workers in healthcare, hospitality, and manufacturing face elevated risk too, since irregular hours mess with sleep and circadian rhythms, both known migraine triggers (Burch et al., 2018). And because migraine affects women at roughly two to three times the rate of men, industries with more women in the workforce, like education and social services, carry a heavier collective burden (Burch et al., 2018). Men, meanwhile, see migraine risk climb in physically demanding jobs, where loud machinery, bright fluorescent lighting, and chemical fumes act as environmental triggers (Affatato et al., 2021).
Now for the part that surprises most business leaders: the biggest financial hit from migraine isn’t people calling in sick. It’s people showing up anyway. Roughly 89% of migraine-related productivity loss comes from “presenteeism,” employees working through an active attack at a fraction of their normal capacity, often because they’re worried about how it’ll look to take time off (Begasse de Dhaem & Sakai, 2022). Absenteeism is a real cost too, and it’s unpredictable by nature, which makes it hard for teams to plan around. Part of the problem is access: many employees simply don’t have fast, effective treatment on hand to stop an attack before it derails their whole day (Yucel et al., 2020).
Summary
Migraine is often dismissed as “just a headache,” but it’s a serious, biologically complex neurological condition that disproportionately affects people in specific jobs and industries. And the financial toll it takes on companies is mostly hidden in plain sight, not in empty chairs, but in people sitting at their desks, in pain, trying to function anyway. Treating migraine as a personal inconvenience rather than an occupational health issue means employers are missing one of the biggest, most fixable drains on workplace productivity.
Call to Action
This is exactly the kind of problem Doctors of Public Health (DrPH) are trained to solve, not through one-on-one treatment, but through systems-level change. Here’s what that looks like in practice:
1. Redesign the environment.
Simple, low-cost changes make a real difference: anti-glare monitor covers, ergonomic workstations, fragrance-free zones, and a quiet room where someone can rest at the first sign of an attack, rather than pushing through it (Begasse de Dhaem et al., 2021).
2. Fix the policies.
Flexible scheduling, hybrid or remote options, and stronger Employee Assistance Programs go a long way. Public health leaders can also push for expanded insurance coverage and community headache clinics, since access to quality care remains uneven across income levels and racial groups (Begasse de Dhaem et al., 2021).
3. Measure it and talk about it.
You can’t fix what you don’t track. Workplace health surveillance can quantify the real cost of presenteeism and the ROI of interventions (Yucel et al., 2020). Just as important: educating managers and executives on what migraine actually is, a neurological disease, not a character flaw or an excuse, helps dismantle the stigma that keeps people from asking for help in the first place.
Migraine isn’t going away, but how workplaces respond to it is entirely within our control. That starts with treating it like the public health issue it is.
Dr. Srivathsan Raghavan is a researcher and practitioner dedicated to solving systemic vulnerabilities within industrial infrastructure. As a Doctor of Public Health, he emphasizes Occupational Health and Safety. He bridges translational science and large-scale corporate execution. Dr. Raghavan integrates rigorous academic theory with real-world operations management to analyze and mitigate environmental health threats. His writing provides evidence-based insights into HAZMAT RMP (Hazardous Materials Responsible Management Person) compliance, offering clinical, scientific, and administrative peers a clear view of how operational design directly affects workforce longevity, population health outcomes, and institutional risk.
References
Affatato, O., Miguet, M., Schiöth, H. B., & Mwinyi, J. (2021). Major sex differences in migraine prevalence among occupational categories: A cross-sectional study using UK Biobank. The Journal of Headache and Pain, 22(1), Article 145. https://doi.org/10.1186/s10194-021-01356-x
American Migraine Foundation. (2021, January 21). What is migraine? https://americanmigrainefoundation.org/resource-library/what-is-migraine/
Begasse de Dhaem, O., Gharedaghi, M. H., Bain, P., Hettie, G., Loder, E., & Burch, R. (2021). Identification of work accommodations and interventions associated with work productivity in adults with migraine: A scoping review. Cephalalgia, 41(6), 760–773. https://doi.org/10.1177/0333102420977852
Begasse de Dhaem, O., & Sakai, F. (2022). Migraine in the workplace. eNeurologicalSci, 27, Article 100408.
Burch, R., Rizzoli, P., & Loder, E. (2018). The prevalence and impact of migraine and severe headache in the United States: Figures and trends from government health studies. Headache: The Journal of Head and Face Pain, 58(4), 496–505. https://doi.org/10.1111/head.13281
Charles, A., & Brennan, K. C. (2009). Cortical spreading depression and migraine. Handbook of Clinical Neurology, 97, 161–171.
Frimpong-Manson, K., Ortiz, Y. T., McMahon, L. R., & Wilkerson, J. L. (2024). Advances in understanding migraine pathophysiology: A bench to bedside review of research insights and therapeutics. Frontiers in Molecular Neuroscience, 17, Article 1355281.
Goadsby, P. J. (2012). Pathophysiology of migraine. Annals of Indian Academy of Neurology, 15(Suppl. 1), S15–S22.
Kessler, R. C., Shahly, V., Stang, P. E., & Lane, M. C. (2010). The associations of migraines and other headaches with work performance: Results from the National Comorbidity Survey Replication (NCS-R). Cephalalgia, 30(6), 722–734. https://doi.org/10.1177/0333102410363766
Leonardi, M., & Raggi, A. (2019). A narrative review on the burden of migraine: When the burden is the impact on people’s life. The Journal of Headache and Pain, 20(1), Article 41.
National Institute of Neurological Disorders and Stroke. (2026, June 9). Migraine. U.S. Department of Health and Human Services. https://www.ninds.nih.gov/health-information/disorders/migraine
Purves, D., Augustine, G. J., Fitzpatrick, D., Katz, L., LaMantia, A. S., McNamara, J., & Williams, S. M. (Eds.). (2001). Neuroscience (2nd ed.). Sinauer Associates.
Yucel, A., Thach, A., Kumar, S., Loden, C., Bensink, M., Goldfarb, N., & Cowan, R. (2020). Estimating the economic burden of migraine on US employers. The American Journal of Managed Care, 26(12), e403–e408. https://doi.org/10.37765/ajmc.2020.88547